These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1548685)
41. Synthesis and in vitro activity of novel quaternary ammonium carbapenems: 2-pyridiniopropyl and 1-pyridinioethyl carbapenems. Ueda Y; Vinet V J Antibiot (Tokyo); 1992 Jun; 45(6):940-53. PubMed ID: 1500362 [TBL] [Abstract][Full Text] [Related]
42. Dual-action penems and carbapenems. Corraz AJ; Dax SL; Dunlap NK; Georgopapadakou NH; Keith DD; Pruess DL; Rossman PL; Then R; Unowsky J; Wei CC J Med Chem; 1992 May; 35(10):1828-39. PubMed ID: 1588561 [TBL] [Abstract][Full Text] [Related]
43. Novel C-2 substituted carbapenem derivatives. Part III. Synthesis and biological activity of 2-(functionalised ethenyl, oxyiminomethyl and alpha-[hydroxy]benzyl)-carbapenems. Clear NJ; Davies JS; Eglington AJ; Fell SC; Hinks JD; Hird NW; Hunt E; Moss SF; Pearson MJ J Antibiot (Tokyo); 1997 Mar; 50(3):237-45. PubMed ID: 9127195 [TBL] [Abstract][Full Text] [Related]
44. 1 beta-Methyl-2-(5-substituted pyrrolidin-3-ylthio)carbapenems. 3. Synthesis and antibacterial activity of BO-2727 and its related compounds. Ohtake N; Okamoto O; Mitomo R; Kato Y; Yamamoto K; Haga Y; Fukatsu H; Nakagawa S J Antibiot (Tokyo); 1997 Jul; 50(7):598-613. PubMed ID: 9711251 [TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological evaluation of 1beta-methylcarbapenems having cyclic thiourea moieties and their related compounds. Han T; Cho JH; Oh CH Eur J Med Chem; 2006 Jul; 41(7):825-32. PubMed ID: 16737759 [TBL] [Abstract][Full Text] [Related]
46. Cephalosporins to carbapenems: 1-oxygenated carbapenems and carbapenams. Rosati RL; Kapili LV; Morrissey P; Retsema JA J Med Chem; 1990 Jan; 33(1):291-7. PubMed ID: 2404120 [TBL] [Abstract][Full Text] [Related]
47. Novel lbeta-methylcarbapenems having cyclic sulfonamide moieties: synthesis and evaluation of in vitro antibacterial activity. Kim SJ; Park HB; Lee JS; Jo NH; Yoo KH; Baek D; Kang BW; Cho JH; Oh CH Eur J Med Chem; 2007 Sep; 42(9):1176-83. PubMed ID: 17418453 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and antibacterial activity of 1beta-methyl-2-[5-(1,2-disubstituted ethyl)pyrrolidin-3-ylthio]carbapenem derivatives. Ahn SH; Jeon H; Choi JH; Baek D; Seo SH; Cho JH; Oh CH Arch Pharm (Weinheim); 2006 Feb; 339(2):67-73. PubMed ID: 16429454 [TBL] [Abstract][Full Text] [Related]
51. Synthesis and antibacterial activities of new 1beta-methylcarbapenems having aminopyrimidinylthioether moiety. Lee KS; Lim JH; Kang YK; Yoo KH; Kim DC; Shin KJ; Kim DJ Eur J Med Chem; 2006 Nov; 41(11):1347-51. PubMed ID: 16973246 [TBL] [Abstract][Full Text] [Related]
52. Carbapenem and penem antibiotics. VI. Synthesis and antibacterial activity of 2-heteroaromatic-thiomethyl and 2-carbamoyloxymethyl 1-methylcarbapenems. Imuta M; Itani H; Ona H; Hamada Y; Uyeo S; Yoshida T Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):663-71. PubMed ID: 2070445 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and biological properties of a new series of anti-MRSA beta-lactams; 2-(thiazol-2-ylthio)carbapenems. Shinagawa H; Yamaga H; Houchigai H; Sumita Y; Sunagawa M Bioorg Med Chem; 1997 Mar; 5(3):601-21. PubMed ID: 9113338 [TBL] [Abstract][Full Text] [Related]
54. Synthesis of novel di- and tricationic carbapenems with potent anti-MRSA activity. Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Shitara E; Iwamatsu K; Atsumi K Bioorg Med Chem Lett; 2009 Jan; 19(2):447-50. PubMed ID: 19056265 [TBL] [Abstract][Full Text] [Related]
55. Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II. Hakimelahi GH; Moosavi-Movahedi AA; Tsay SC; Tsai FY; Wright JD; Dudev T; Hakimelahi S; Lim C J Med Chem; 2000 Oct; 43(20):3632-40. PubMed ID: 11020277 [TBL] [Abstract][Full Text] [Related]
56. Carbapenem and penem antibiotics. VII. Synthesis and antibacterial activity of 1 beta-methyl-2-(quaternary heteroaromatic-thiomethyl) carbapenems. Imuta M; Itani H; Ona H; Konoike T; Uyeo S; Kimura Y; Miwa H; Matsuura S; Yoshida T Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):672-8. PubMed ID: 2070446 [TBL] [Abstract][Full Text] [Related]
57. Synthesis and structure-activity relationships of 1beta-methylcarbapenems with quaternary ammonium side chains. Ishikawa K; Kojima K; Miyauchi M; Endo R; Yasuda H; Kawamoto I J Antibiot (Tokyo); 1998 Aug; 51(8):757-70. PubMed ID: 9766468 [TBL] [Abstract][Full Text] [Related]
58. In vivo activities of peptidic prodrugs of novel aminomethyl tetrahydrofuranyl-1 beta-methylcarbapenems. Weiss WJ; Mikels SM; Petersen PJ; Jacobus NV; Bitha P; Lin YI; Testa RT Antimicrob Agents Chemother; 1999 Mar; 43(3):460-4. PubMed ID: 10049251 [TBL] [Abstract][Full Text] [Related]
59. Synthesis and structure-activity relationships of a novel oral carbapenem, CS-834. Miyauchi M; Endo R; Hisaoka M; Yasuda H; Kawamoto I J Antibiot (Tokyo); 1997 May; 50(5):429-39. PubMed ID: 9207914 [TBL] [Abstract][Full Text] [Related]
60. Novel lbeta-methylcarbapenems having cyclic sulfonamide moieties: synthesis and evaluation of in-vitro biological activity - part II. Kim SJ; Cho JH; Oh CH Arch Pharm (Weinheim); 2009 Sep; 342(9):528-32. PubMed ID: 19598286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]